Reaction
Neutrophil Percentage Decreased reporting signals
As of the last recalculation, Neutrophil Percentage Decreased appears in 525 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 47.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 22 | 47.0 | 47.1 |
| Letrozole Tablets | 47 | 42.4 | 42.5 |
| Letrozole | 52 | 37.0 | 37.1 |
| Niraparib | 17 | 31.3 | 31.4 |
| Palbociclib | 54 | 24.9 | 24.9 |
| Crizotinib | 5 | 15.7 | 15.7 |
| Polatuzumab Vedotin | 3 | 12.3 | 12.3 |
| Emicizumab | 3 | 9.7 | 9.7 |